Spine biologics market to grow at CAGR of 4.09% through 2022

Written by Shayna Korol | June 11, 2018 | Print  |

The global spine biologics market is expected to grow at a compound annual growth rate of 4.09 percent from 2018 to 2022, according to a 360 Market Updates report.

Key vendors in the spine biologics market include:

1. Alphatec Spine

2. Globus Medical

3. Medtronic

4. NuVasive

5. AlloSource

6. Amendia

7. ChoiceSpine

8. DePuy Synthes

9. Exactech

10. Harvest Technologies

More articles on biologics:

3 things to know about Lattice Biologics

8 key surgeon Q&As on biologics in orthopedics & spine

International Stem Cell Corp. to launch joint supplement for osteoarthritis pain in Q3 2018

© Copyright ASC COMMUNICATIONS 2018. Interested in LINKING to or REPRINTING this content? View our policies here.